Table 1

Summary of the most frequent copy number gains and losses. Table listing the most frequent copy number gains and losses, sorted in decreasing order, in relation to tumor stage. Columns give the cytoband, start reporter, end reporter, size (Mbp), and candidate genes in the region.

Cytoband

Start reporter

End reporter

Size (Mbp)

Candidate genes


Gains (≥ 60%)


5p15.33

RP11-811I15

CTD-2296H22

1.8

TERT

7p22.3

CTD-2245C5

RP11-745M18

2.3

MAD1L1, NUDT1

7p11.2

RP11-449G3

RP11-535N12

1.1

8q24.13-q24.23

RP11-150N13

RP11-141J23

10.5

MYC, WISP1

8q24.3

CTD-2330C15

CTD-2300I18

1.5

FOXH1

10q26.3

RP13-137A17

RP11-1065F16

0.8

11q13.3-11q13.4

RP11-433A18

RP11-574F24

1.8

12p13.33

CTD-2094C14

RP11-574G8

0.2

14q32.33

CTD-2344P12

RP11-603L1

0.4

AKT1

16p13.3

RP11-344L6

RP11-680M24

3.2

17p13.1

RP11-205D17

RP11-63C7

0.6

19p13.3

RP11-519F9

RP11-81M8

1.6

19q13.42

CTD-2503B7

RP11-528E9

0.3

20q13.33

CTD-2022N11

RP11-350G15

2.4


Losses (≥ 40%)


3p26.3-p24.2

RP11-359E9

RP11-512O18

3.5

RARB, TOP2B

3p14.2-p14.1

RP11-350E21

RP11-175F9

6.9

FHIT

3p14.1-p13

RP11-607B7

RP11-744B4

5.8

5q12.3-q13.1

RP11-158G8

RP11-633F2

0.9

PIK3R1

8p23.2

RP11-46M15

RP11-593J22

2.2

9p24.3-p24.2

RP11-272N16

RP11-778P24

3.1

MTAP, CDKN2A, CDKN2B

9p23

RP11-6H18

RP11-312G1

1.9

9p21.3

RP11-113D19

RP11-16P12

5.2

11q25

RP11-217L21

CTD-2270L17

2.4

ATM


Carneiro et al. BMC Cancer 2008 8:98   doi:10.1186/1471-2407-8-98

Open Data